LeMaitre Vascular, Inc.

LMAT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap$2,068,727$1,261,037$1,011,290$1,062,716
- Cash$25,610$24,269$19,134$13,855
+ Debt$185,685$19,095$16,596$15,937
Enterprise Value$2,228,802$1,255,863$1,008,752$1,064,798
Revenue$219,863$193,484$161,651$154,424
% Growth13.6%19.7%4.7%
Gross Profit$150,901$127,049$104,896$101,382
% Margin68.6%65.7%64.9%65.7%
EBITDA$66,750$48,990$36,923$45,981
% Margin30.4%25.3%22.8%29.8%
Net Income$44,038$30,105$20,636$26,907
% Margin20%15.6%12.8%17.4%
EPS Diluted1.931.340.931.25
% Growth44%44.1%-25.6%
Operating Cash Flow$44,124$36,751$25,378$35,102
Capital Expenditures-$6,962-$7,265-$3,229-$4,882
Free Cash Flow$37,162$29,486$22,149$30,220
LeMaitre Vascular, Inc. (LMAT) Financial Statements & Key Stats | AlphaPilot